Eotaxin and impaired lung function in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 6, 1999, Pages 1952-1956

  Nakamura, Hidetoshi ^a,b,c   Weiss, Scott T ^a,b,c   Israel, Elliot ^a,b,c   Luster, Andrew D ^a,b,c   Drazen, Jeffrey M ^a,b,c   Lilly, Craig M ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; IMMUNOGLOBULIN E;

ADULT; ARTICLE; ASTHMA; CHEMOTAXIS; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033430375     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.6.9811089     Document Type: Article

References (35)

1. Dunnill, M. S. 1960. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13:27-33.
2. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
3. Laitinen, A., and L. A. Laitinen. 1991. Cellular infiltrates in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1159-1160.
4. Vignola, A. M., P. Chanez, A. M. Campbell, F. Souques, B. Lebel, I. Enander, and J. Bousquet. 1998. Airway inflammation in mild intermittent and in persistent asthma. Am. J. Respir. Crit. Care Med. 157:403-409.
5. Wardlaw, A. J., S. Dunnette, G. J. Gleich, J. V. Collins, and A. B. Kay. 1988. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62-69.
6. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
7. Daugherty, B. L., S. J. Siciliano, J. A. DeMartino, L. Malkowitz, A. Sirotina, and M. S. Springer. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183:2349-2354.
8. Uguccioni, M., C. R. Mackay, B. Ochensberger, P. Loetscher, S. Rhis, G. J. LaRosa, P. Rao, P. D. Ponath, M. Baggiolini, and C. A. Dahinden. 1997. High expression of the chemokine receptor CCR3 in human blood basophils: role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Invest. 100:1137-1143.
9. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005-2007.
10. Jose, P. J., D. A. Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179;881-887.
11. Lilly, C. M., H. Nakamura, H. Kesselman, K. Nagler-Anderson, E. A. Garcia-Zepeda, M. E. Rothenberg, J. M. Drazen, and A. D. Luster. 1997. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J. Clin. Invest. 99:1767-1773.
12. Garcia-Zepeda, E. A., M. E. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449-456.
13. Lamkhioued, B., P. M. Renzi, S. Abi-Younes, E. A. Garcia-Zepada, Z. Allakhverdi, O. Ghaffar, M. D. Rothenberg, A. D. Luster, and Q. Hamid. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J. Immunol. 159:4593-4601.
14. Ying, S., D. S. Robinson, Q. Meng, J. Rottman, R. Kennedy, D. J. Ringler, C. R. Mackay, B. L. Daugherty, M. S. Springer, S. R. Durham, T. J. Williams, and A. B. Kay. 1997. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma: association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur. J. Immunol. 27:3507-3516.
15. Horn, B. R., E. D. Robin, J. Theodore, and A. Van Kessel. 1975. Total eosinophil counts in the management of bronchial asthma. N. Engl. J. Med. 292:1152-1155.
16. Baigelman, W., S. Chodosh, D. Pizzuto, and L. A. Cupples. 1983. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. Am. J. Med. 75:929-936.
17. CSGA. 1997. A genome-wide search for asthma susceptibility loci in ethnically diverse populations: the Collaborative Study on the Genetics of Asthma (CSGA). Nat. Genet. 15:389-392.
18. Sears, M. R., B. Burrows, E. M. Flannery, G. P. Herbison, C. J. Hewitt, and M. D. Holdaway. 1991. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N. Engl. J. Med. 325:1067-1071.
19. Sears, M. R., B. Burrows, G. P. Herbison, E. M. Flannery, and M. D. Holdaway. 1993. Atopy in childhood: 3. Relationship with pulmonary function and airway responsiveness. Clin. Exp. Allergy 23:957-963.
20. Burrows, B., M. R. Sears, E. M. Flannery, G. P. Herbison, and M. D. Holdaway. 1992. Relationships of bronchial responsiveness assessed by methacholine to serum IgE, lung function, symptoms, and diagnoses in 11-year-old New Zealand children. J. Allergy Clin. Immunol. 90:376-385.
21. Sears, M. R., C. M. Chow, and D. J. Morseth. 1980. Serum total IgE in normal subjects and the influence of a family history of allergy. Clin. Allergy 10:423-431.
22. Laitinen, L. A., A. Laitinen, and T. Haahtela. 1992. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J. Allergy Clin. Immunol. 90:32-42.
23. Zieg, G., G. Lack, R. J. Harbeck, E. W. Gelfand, and D. Y. Leung. 1994. In vivo effects of glucocorticoids on IgE production. J. Allergy Clin. Immunol. 94:222-230.
24. American Thoracic Society. 1991. Lung function testing: selection of reference values and interpretive strategies. Am. Rev. Respir. Dis. 144:1202-1218.
25. Guidelines for the diagnosis and management of asthma. National Institute of Health, National Heart, Lung, and Blood Institute, Bethesda, MD. 97-4051. 1997:8.
26. Parra, A., I. Prieto, M. L. Sanz, I. Dieguez, A, Resano, and A. K. Oehling. 1996. Serum ECP levels in asthmatic patients: comparison with other follow-up parameters. Allergy Asthma Proc. 17:191-197.
27. Gleich, G. J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422-436.
28. Ayars, G. H., L. C. Altman, M. M. McManus, J. M. Agosti, C. Baker, D. L. Luchtel, D. A. Loegering, and G. J. Gleich. 1989. Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro. Am. Rev. Respir. Dis. 140:125-131.
29. Weller, P. F., C. W. Lee, D. W. Foster, E. J. Corey, K. F. Austen, and R. A. Lewis. 1983. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc. Natl. Acad. Sci. U.S.A. 80:7626-7630.
30. Rothenberg, M. E., J. A. MacLean, E. Pearlman, A. D. Luster, and P. Leder. 1997. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185:785-790.
31. Teixeira, M. M., T. N. Wells, N. W. Lukacs, A. E. Proudfoot, S. L. Kunkel, T. J. Williams, and P. G. Hellewell. 1997. Chemokine-induced eosinophil recruitment: evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 100:1657-1666.
32. Humbles, A. A., D. M. Conroy, S. Marleau, S. M. Rankin, R. T. Palframan, A. E. Proudfoot, T. N. Wells, D. Li, P. K. Jeffery, D. A. Griffiths-Johnson, T. J. Williams, and P. J. Jose. 1997. Kinetics of cotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186:601-612.
33. Gonzalo, J. A., C. M. Lloyd, D. Wen, J. P. Albar, T. N. Wells, A. Proudfoot, C, Martinez-A, M. Dorf, T. Bjerke, A. J. Coyle, and J. C. Gutierrez-Ramos. 1998. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. 188:157-167.
34. Robinson, D. S., S. R. Durham, and A. B. Kay. 1993. Cytokines: 3. Cytokines in asthma. Thorax 48:845-853.
35. Gerber, B. O., M. P. Zanni, M. Uguccioni, M. Loetscher, C. R. Mackay, W. J. Pichler, N. Yawalkar, M. Baggiolini, and B. Moser. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes colocalizing with eosinophils. Curr. Biol. 7:836-843.